HLA-A*0201 | B2M | p53 (RMPEAAPPV)

HLA-A*0201 | B2M | p53 (RMPEAAPPV)

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
RisuteganibALG-1001; AM011; AM-011(Allegro Ophthalmics)Phase 1 ClinicalAllegro Ophthalmics Llc
Diabetic macular oedema; Geographic Atrophy; Macular Degeneration; Diabetic Retinopathy
Details